# Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

> **NCT06746701** · — · RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 400 (estimated)

## Conditions studied

- HBV

## Interventions

- **DRUG:** Peg-IFNα-2b combined with NA
- **DRUG:** Nucleotide Analogues

## Key facts

- **NCT ID:** NCT06746701
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-25
- **Primary completion:** 2027-05-25
- **Final completion:** 2029-05-25
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06746701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06746701, "Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06746701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*